America's First Exclusively Orphan Drug Company:

A Liquid Alternative to the Mercaptopurine Tablet

The first FDA-Approved oral suspension form of mercaptopurine, PURIXAN offers flexibility and accuracy of dosing, consistent absorption and is a palatable alternative to current mercaptopurine therapies.